The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience

The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience

Background/Aim. The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of targeted therapies. This study aimed to assess the efficacy of generic imatinib in CML patients treated in our center. Methods. The study was retrospective. It included 101 patients diagnosed...

Full description

Saved in:
Bibliographic Details
Main Authors: Urošević Ivana, Perčić Ivanka, Dragičević-Jojkić Marina, Dokić Marina, El Farra Amir, Savić Aleksandar, Milošević Ivana, Vlaisavljević Nada, Sekulić Borivoj, Balint Bela
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Series:Vojnosanitetski Pregled
Subjects:
leukemia, myeloid, chronic-phase
imatinib mesylate
drugs, generic
survival
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900095U.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900095U.pdf

Similar Items